New insights into immune cells in cancer immunotherapy: from epigenetic modification, metabolic modulation to cell communication

被引:6
|
作者
Qin, Sha [1 ,2 ]
Xie, Bin [1 ]
Wang, Qingyi [1 ,2 ]
Yang, Rui [1 ,2 ]
Sun, Jingyue [1 ,2 ]
Hu, Chaotao [3 ]
Liu, Shuang [4 ]
Tao, Yongguang [1 ,5 ,6 ]
Xiao, Desheng [1 ,2 ]
机构
[1] Cent South Univ, Xiangya Hosp, Dept Pathol, Changsha, Hunan, Peoples R China
[2] Cent South Univ, Sch Basic Med Sci, Xiangya Sch Med, Dept Pathol, Changsha, Hunan, Peoples R China
[3] Univ Chinese Acad Sci, Med Sch, Regenerat Med, Beijing, Peoples R China
[4] China Univ, Cent South Univ, Xiangya Hosp, Dept Oncol,Inst Med Sci,Natl Clin Res Ctr Geriatr, Changsha, Hunan, Peoples R China
[5] Cent South Univ, Canc Res Inst, NHC Key Lab Carcinogenesis, Changsha, Hunan, Peoples R China
[6] Cent South Univ, Sch Basic Med, Changsha, Hunan, Peoples R China
来源
MEDCOMM | 2024年 / 5卷 / 06期
基金
中国国家自然科学基金;
关键词
cancer immunotherapy; epigenetic modification; immune cells communication; metabolic modulation; REGULATORY T-CELLS; INFILTRATING LYMPHOCYTE THERAPY; TUMOR-ASSOCIATED MACROPHAGES; FDA APPROVAL; LUNG-CANCER; SUPPRESSOR-CELLS; DENDRITIC CELLS; PROGNOSTIC BIOMARKER; MURINE MODEL; CROSS-TALK;
D O I
10.1002/mco2.551
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Cancer is one of the leading causes of death worldwide, and more effective ways of attacking cancer are being sought. Cancer immunotherapy is a new and effective therapeutic method after surgery, radiotherapy, chemotherapy, and targeted therapy. Cancer immunotherapy aims to kill tumor cells by stimulating or rebuilding the body's immune system, with specific efficiency and high safety. However, only few tumor patients respond to immunotherapy and due to the complex and variable characters of cancer immune escape, the behavior and regulatory mechanisms of immune cells need to be deeply explored from more dimensions. Epigenetic modifications, metabolic modulation, and cell-to-cell communication are key factors in immune cell adaptation and response to the complex tumor microenvironment. They collectively determine the state and function of immune cells through modulating gene expression, changing in energy and nutrient demands. In addition, immune cells engage in complex communication networks with other immune components, which are mediated by exosomes, cytokines, and chemokines, and are pivotal in shaping the tumor progression and therapeutic response. Understanding the interactions and combined effects of such multidimensions mechanisms in immune cell modulation is important for revealing the mechanisms of immunotherapy failure and developing new therapeutic targets and strategies. Relationships between immune cell metabolism, epigenetics modulation, and cancer immunotherapy clinical efficiency. Epigenetic regulation (including DNA methylation, RNA methylation, histone modification, and chromatin remodeling) of immune cells can influence the differentiation and activity of immune cells, while metabolic status influences the energy supply and reactivity of immune cells, and they are participated in cancer immunotherapy and influenced clinical effect through immune cells as a bridge. (Me, methylation; U, ubiquitination; Ac, acetylation; P, phosphorylation). image
引用
收藏
页数:32
相关论文
共 50 条
  • [31] Role of cell-to-cell communication in cancer: New features, insights, and directions
    Eugenin, Eliseo A.
    CANCER REPORTS, 2019, 2 (06)
  • [32] Modulation of cancer immunotherapy by the microbiome: Insights from computational analyses of preclinical studies.
    Harkos, Constantinos
    Hadjigeorgiou, Andreas
    Mishra, Aditya K.
    Morad, Golnaz
    Johnson, Sarah
    Ajami, Nadim J.
    Stylianopoulos, Triantafyllos
    Munn, Lance L.
    Wargo, Jeniffer A.
    Jain, Rakesh K.
    CANCER IMMUNOLOGY RESEARCH, 2022, 10 (12)
  • [33] New Era of Regulatory T Cells in Tumor Immunity: Insights in Cancer Immunotherapy
    Sheu, Bor-Ching
    Chang, Wen-Chun
    Huang, Su-Cheng
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2010, 109 (01) : 1 - 3
  • [34] New insights on anti-tumor immunity of CD8+ T cells: cancer stem cells, tumor immune microenvironment and immunotherapy
    Lin, Yibin
    Song, Yifu
    Zhang, Yaochuan
    Li, Xiaodong
    Kan, Liang
    Han, Sheng
    JOURNAL OF TRANSLATIONAL MEDICINE, 2025, 23 (01)
  • [35] Decoding the stem cells-immune cell dialogues for cancer immunotherapy.
    Miao, Yuxuan Phoenix
    Truong, Cynthia
    Fuchs, Elaine
    CANCER RESEARCH, 2021, 81 (13)
  • [36] Immunogenic Material Vaccine for Cancer Immunotherapy by Structure-Dependent Immune Cell Trafficking and Modulation
    Yang, Wei
    Cao, Jianwei
    Di, Sichen
    Chen, Wenjin
    Cheng, Hui
    Ren, Hongze
    Xie, Yujie
    Chen, Liang
    Yu, Meihua
    Chen, Yu
    Cui, Xingang
    ADVANCED MATERIALS, 2024, 36 (27)
  • [37] New insights into cancer immune checkpoints landscape from single-cell RNA sequencing
    Wang, Qian
    He, Jiahui
    Lei, Tianyu
    Li, Xiaohui
    Yue, Shengqin
    Liu, Chao
    Hu, Qinyong
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2025, 1880 (03):
  • [38] Immune Checkpoints and Innate Lymphoid Cells-New Avenues for Cancer Immunotherapy
    Jacquelot, Nicolas
    Ghaedi, Maryam
    Warner, Kathrin
    Chung, Douglas C.
    Crome, Sarah Q.
    Ohashi, Pamela S.
    CANCERS, 2021, 13 (23)
  • [39] Immune Cell-Derived Extracellular Vesicles - New Strategies in Cancer Immunotherapy
    Yang, Pengxiang
    Peng, Yong
    Feng, Yuan
    Xu, Zhuoying
    Feng, Panfeng
    Cao, Jie
    Chen, Ying
    Chen, Xiang
    Cao, Xingjian
    Yang, Yumin
    Jie, Jing
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [40] The Interplay between Circulating Tumor Cells and the Immune System: From Immune Escape to Cancer Immunotherapy
    Leone, Kevin
    Poggiana, Cristina
    Zamarchi, Rita
    DIAGNOSTICS, 2018, 8 (03):